vs

Side-by-side financial comparison of CABOT CORP (CBT) and IAC Inc. (IAC). Click either name above to swap in a different company.

CABOT CORP is the larger business by last-quarter revenue ($849.0M vs $646.0M, roughly 1.3× IAC Inc.). CABOT CORP runs the higher net margin — 8.6% vs -11.9%, a 20.5% gap on every dollar of revenue. On growth, IAC Inc. posted the faster year-over-year revenue change (-10.5% vs -11.1%). CABOT CORP produced more free cash flow last quarter ($57.0M vs $31.4M). Over the past eight quarters, IAC Inc.'s revenue compounded faster (1.7% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

IAC Inc. is an American holding company that owns brands worldwide, mostly in media and Internet. The company originated in 1996 as HSN Inc., the holding company of Home Shopping Network and USA Network before changing its name to USA Networks, Inc. in 1999. The firm's television assets then were sold to Vivendi in 2002.

CBT vs IAC — Head-to-Head

Bigger by revenue
CBT
CBT
1.3× larger
CBT
$849.0M
$646.0M
IAC
Growing faster (revenue YoY)
IAC
IAC
+0.6% gap
IAC
-10.5%
-11.1%
CBT
Higher net margin
CBT
CBT
20.5% more per $
CBT
8.6%
-11.9%
IAC
More free cash flow
CBT
CBT
$25.6M more FCF
CBT
$57.0M
$31.4M
IAC
Faster 2-yr revenue CAGR
IAC
IAC
Annualised
IAC
1.7%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CBT
CBT
IAC
IAC
Revenue
$849.0M
$646.0M
Net Profit
$73.0M
$-76.8M
Gross Margin
24.9%
69.8%
Operating Margin
15.2%
-17.5%
Net Margin
8.6%
-11.9%
Revenue YoY
-11.1%
-10.5%
Net Profit YoY
-21.5%
61.4%
EPS (diluted)
$1.37
$-0.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
IAC
IAC
Q4 25
$849.0M
$646.0M
Q3 25
$899.0M
$589.8M
Q2 25
$923.0M
$586.9M
Q1 25
$936.0M
$570.5M
Q4 24
$955.0M
$721.4M
Q3 24
$1.0B
$642.0M
Q2 24
$1.0B
$634.4M
Q1 24
$1.0B
$624.3M
Net Profit
CBT
CBT
IAC
IAC
Q4 25
$73.0M
$-76.8M
Q3 25
$43.0M
$-21.9M
Q2 25
$101.0M
$211.5M
Q1 25
$94.0M
$-216.8M
Q4 24
$93.0M
$-199.0M
Q3 24
$137.0M
$-243.7M
Q2 24
$109.0M
$-142.2M
Q1 24
$84.0M
$45.0M
Gross Margin
CBT
CBT
IAC
IAC
Q4 25
24.9%
69.8%
Q3 25
24.5%
64.8%
Q2 25
26.4%
65.6%
Q1 25
25.7%
64.0%
Q4 24
24.6%
65.8%
Q3 24
24.0%
62.1%
Q2 24
25.2%
60.1%
Q1 24
24.1%
58.4%
Operating Margin
CBT
CBT
IAC
IAC
Q4 25
15.2%
-17.5%
Q3 25
15.2%
-3.5%
Q2 25
18.1%
0.1%
Q1 25
17.3%
6.3%
Q4 24
16.2%
6.7%
Q3 24
15.0%
1.3%
Q2 24
16.9%
-3.4%
Q1 24
15.3%
-10.2%
Net Margin
CBT
CBT
IAC
IAC
Q4 25
8.6%
-11.9%
Q3 25
4.8%
-3.7%
Q2 25
10.9%
36.0%
Q1 25
10.0%
-38.0%
Q4 24
9.7%
-27.6%
Q3 24
13.7%
-38.0%
Q2 24
10.7%
-22.4%
Q1 24
8.2%
7.2%
EPS (diluted)
CBT
CBT
IAC
IAC
Q4 25
$1.37
$-0.96
Q3 25
$0.80
$-0.27
Q2 25
$1.86
$2.57
Q1 25
$1.69
$-2.64
Q4 24
$1.67
$-2.36
Q3 24
$2.41
$-2.93
Q2 24
$1.94
$-1.71
Q1 24
$1.49
$0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
IAC
IAC
Cash + ST InvestmentsLiquidity on hand
$230.0M
$960.2M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$1.6B
$4.7B
Total Assets
$3.8B
$7.1B
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
IAC
IAC
Q4 25
$230.0M
$960.2M
Q3 25
$258.0M
$1.0B
Q2 25
$239.0M
$1.1B
Q1 25
$213.0M
$1.2B
Q4 24
$183.0M
$1.4B
Q3 24
$223.0M
$1.3B
Q2 24
$197.0M
$1.3B
Q1 24
$206.0M
$1.3B
Total Debt
CBT
CBT
IAC
IAC
Q4 25
$1.4B
Q3 25
$1.1B
$1.4B
Q2 25
$1.4B
Q1 25
Q4 24
Q3 24
$1.1B
Q2 24
Q1 24
Stockholders' Equity
CBT
CBT
IAC
IAC
Q4 25
$1.6B
$4.7B
Q3 25
$1.6B
$4.8B
Q2 25
$1.5B
$4.9B
Q1 25
$1.4B
$4.7B
Q4 24
$1.4B
$5.6B
Q3 24
$1.4B
$5.8B
Q2 24
$1.3B
$6.0B
Q1 24
$1.4B
$6.1B
Total Assets
CBT
CBT
IAC
IAC
Q4 25
$3.8B
$7.1B
Q3 25
$3.8B
$7.2B
Q2 25
$3.8B
$7.4B
Q1 25
$3.8B
$7.2B
Q4 24
$3.6B
$9.7B
Q3 24
$3.7B
$9.8B
Q2 24
$3.6B
$10.2B
Q1 24
$3.6B
$10.4B
Debt / Equity
CBT
CBT
IAC
IAC
Q4 25
0.30×
Q3 25
0.70×
0.30×
Q2 25
0.30×
Q1 25
Q4 24
Q3 24
0.75×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
IAC
IAC
Operating Cash FlowLast quarter
$126.0M
$36.6M
Free Cash FlowOCF − Capex
$57.0M
$31.4M
FCF MarginFCF / Revenue
6.7%
4.9%
Capex IntensityCapex / Revenue
8.1%
0.8%
Cash ConversionOCF / Net Profit
1.73×
TTM Free Cash FlowTrailing 4 quarters
$401.0M
$44.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
IAC
IAC
Q4 25
$126.0M
$36.6M
Q3 25
$219.0M
$30.1M
Q2 25
$249.0M
$-2.8M
Q1 25
$73.0M
$63.0K
Q4 24
$124.0M
$110.1M
Q3 24
$204.0M
$95.3M
Q2 24
$207.0M
$85.0M
Q1 24
$176.0M
$64.1M
Free Cash Flow
CBT
CBT
IAC
IAC
Q4 25
$57.0M
$31.4M
Q3 25
$155.0M
$25.3M
Q2 25
$188.0M
$-7.2M
Q1 25
$1.0M
$-4.6M
Q4 24
$47.0M
$104.8M
Q3 24
$112.0M
$92.0M
Q2 24
$155.0M
$81.6M
Q1 24
$133.0M
$61.1M
FCF Margin
CBT
CBT
IAC
IAC
Q4 25
6.7%
4.9%
Q3 25
17.2%
4.3%
Q2 25
20.4%
-1.2%
Q1 25
0.1%
-0.8%
Q4 24
4.9%
14.5%
Q3 24
11.2%
14.3%
Q2 24
15.3%
12.9%
Q1 24
13.1%
9.8%
Capex Intensity
CBT
CBT
IAC
IAC
Q4 25
8.1%
0.8%
Q3 25
7.1%
0.8%
Q2 25
6.6%
0.8%
Q1 25
7.7%
0.8%
Q4 24
8.1%
0.7%
Q3 24
9.2%
0.5%
Q2 24
5.1%
0.5%
Q1 24
4.2%
0.5%
Cash Conversion
CBT
CBT
IAC
IAC
Q4 25
1.73×
Q3 25
5.09×
Q2 25
2.47×
-0.01×
Q1 25
0.78×
Q4 24
1.33×
Q3 24
1.49×
Q2 24
1.90×
Q1 24
2.10×
1.42×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

IAC
IAC

Print$168.5M26%
Performance Marketing$101.2M16%
Care.com$85.7M13%
Subscription$69.5M11%
Licensing And Other$43.8M7%
Consumer Revenue$43.2M7%
Advertising$35.9M6%
Project And Other Print$33.6M5%
Advertising Google$28.9M4%
Newsstand$22.4M3%
Emerging Other$19.6M3%

Related Comparisons